Home Page
Trending Articles
-
Multiplexed single-cell characterization of alternative polyadenylation regulators.
Cell. 2024. PMID: 38925112
-
Pan-cancer proteogenomics expands the landscape of therapeutic targets.
Cell. 2024. PMID: 38917788
-
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC.
N Engl J Med. 2024. PMID: 38924756